{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T05:58:02.421346+00:00","published_at":"2026-10-17T04:45:45.751176+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:n0uudgvym1gq","event_type":"GC_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:james-r-kasinger-crsp","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:e9a5c69acc146fbb30c88226413138788ec6364a0fca7d85e4f6197e79f4f3ea"],"summary":"James R. Kasinger executive of CRISPR Therapeutics AG, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pq75n01ith13w","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:naimish-patel-m-d-crsp","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:b88b7de8b1932f76df41e30ba7cba0c64bd6211bdef2e63f26715c2619a18a99"],"summary":"Naimish Patel, M.D. executive of CRISPR Therapeutics AG, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:68o8fo165cv4k","event_type":"CFO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:raju-prasad-ph-d-crsp","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:a8412d5bb50c0528d1ebe2dad4857eedcbae3a2b6b1c411515139731e2e460f1"],"summary":"Raju Prasad, Ph.D. executive of CRISPR Therapeutics AG, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:88ac12joutba","event_type":"CEO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:samarth-kulkarni-ph-d-crsp","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:20"],"evidence_ids":["alpha:projection-evidence:document:a6f402a1d0006994498d4b437c6a7dbe03aa7dead593633b3e83a95a13a661a2"],"summary":"Samarth Kulkarni, Ph.D. executive of CRISPR Therapeutics AG, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gxqt3p1pywqjv","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:briggs-w-morrison-m-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Briggs W. Morrison, M.D. seat on CRISPR Therapeutics AG, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mlt78dc1mhgp","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:christian-rommel-ph-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Christian Rommel, Ph.D. seat on CRISPR Therapeutics AG, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:32q10l1mjtixh","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:sandesh-mahatme-ll-m","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Sandesh Mahatme, LL.M. seat on CRISPR Therapeutics AG, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:102p98v19b133t","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:maria-fardis-ph-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Maria Fardis, Ph.D. seat on CRISPR Therapeutics AG, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cuy8i914kq7np","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:h-edward-fleming-jr-m-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"H. Edward Fleming, Jr., M.D. seat on CRISPR Therapeutics AG, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qw4gk81vygei4","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:douglas-a-treco-ph-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Douglas A. Treco, Ph.D. seat on CRISPR Therapeutics AG, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1950itxs9dqyj","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:john-t-greene","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"John T. Greene seat on CRISPR Therapeutics AG, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fc3s2aq8n9g8","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:katherine-a-high-md","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Katherine A. High, M.D. seat on CRISPR Therapeutics AG, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1i5y6q717fsanj","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:committee:crispr-therapeutics-ag:audit-chair-compensation","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Audit · Chair; Compensation committee of CRISPR Therapeutics AG, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ba6vgb14hyo9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:john-t-greene","alpha:committee:crispr-therapeutics-ag:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"John T. Greene member of Audit · Chair; Compensation, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:apuqnz98x29x","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:katherine-a-high-md","alpha:committee:crispr-therapeutics-ag:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_record:25"],"evidence_ids":["alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37"],"summary":"Katherine A. High, M.D. member of Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3nqvdfrqtqbv","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:samarth-kulkarni-ph-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Samarth Kulkarni, Ph.D. seat on CRISPR Therapeutics AG, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nadcbnaldond","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:ali-behbahani-m-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Ali Behbahani, M.D. seat on CRISPR Therapeutics AG, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:llg1iw4e2m2k","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:45.751176+00:00","subject_ids":["alpha:person:simeon-j-george-m-d","alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4"],"caused_claim_ids":["alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98"],"summary":"Simeon J. George, M.D. seat on CRISPR Therapeutics AG, effective 2015-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:6","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ali-behbahani-m-d","object_label":"Ali Behbahani, M.D.","object_source_name_forms":[],"value":"Ali Behbahani, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ali-behbahani-m-d","name":"Ali Behbahani, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:7","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:briggs-w-morrison-m-d","object_label":"Briggs W. Morrison, M.D.","object_source_name_forms":[],"value":"Briggs W. Morrison, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:briggs-w-morrison-m-d","name":"Briggs W. Morrison, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:8","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christian-rommel-ph-d","object_label":"Christian Rommel, Ph.D.","object_source_name_forms":[],"value":"Christian Rommel, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christian-rommel-ph-d","name":"Christian Rommel, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:9","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:douglas-a-treco-ph-d","object_label":"Douglas A. Treco, Ph.D.","object_source_name_forms":[],"value":"Douglas A. Treco, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:douglas-a-treco-ph-d","name":"Douglas A. Treco, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:10","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:h-edward-fleming-jr-m-d","object_label":"H. Edward Fleming, Jr., M.D.","object_source_name_forms":[],"value":"H. Edward Fleming, Jr., M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:h-edward-fleming-jr-m-d","name":"H. Edward Fleming, Jr., M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:11","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-t-greene","object_label":"John T. Greene","object_source_name_forms":[],"value":"John T. Greene: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-t-greene","name":"John T. Greene"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:12","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:katherine-a-high-md","object_label":"Katherine A. High, M.D.","object_source_name_forms":[],"value":"Katherine A. High, M.D.: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:katherine-a-high-md","name":"Katherine A. High, M.D."},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:13","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:maria-fardis-ph-d","object_label":"Maria Fardis, Ph.D.","object_source_name_forms":[],"value":"Maria Fardis, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:maria-fardis-ph-d","name":"Maria Fardis, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:14","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:samarth-kulkarni-ph-d","object_label":"Samarth Kulkarni, Ph.D.","object_source_name_forms":[],"value":"Samarth Kulkarni, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:samarth-kulkarni-ph-d","name":"Samarth Kulkarni, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:15","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sandesh-mahatme-ll-m","object_label":"Sandesh Mahatme, LL.M.","object_source_name_forms":[],"value":"Sandesh Mahatme, LL.M.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sandesh-mahatme-ll-m","name":"Sandesh Mahatme, LL.M."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:16","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:simeon-j-george-m-d","object_label":"Simeon J. George, M.D.","object_source_name_forms":[],"value":"Simeon J. George, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:simeon-j-george-m-d","name":"Simeon J. George, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:17","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:james-r-kasinger-crsp","object_label":"James R. Kasinger","object_source_name_forms":[],"value":"James R. Kasinger: General Counsel and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:james-r-kasinger-crsp","name":"James R. Kasinger"},"title":"General Counsel and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:e9a5c69acc146fbb30c88226413138788ec6364a0fca7d85e4f6197e79f4f3ea","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:57.947188+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:18","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:naimish-patel-m-d-crsp","object_label":"Naimish Patel, M.D.","object_source_name_forms":[],"value":"Naimish Patel, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:naimish-patel-m-d-crsp","name":"Naimish Patel, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:b88b7de8b1932f76df41e30ba7cba0c64bd6211bdef2e63f26715c2619a18a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:58.464779+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:19","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:raju-prasad-ph-d-crsp","object_label":"Raju Prasad, Ph.D.","object_source_name_forms":[],"value":"Raju Prasad, Ph.D.: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:raju-prasad-ph-d-crsp","name":"Raju Prasad, Ph.D."},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:a8412d5bb50c0528d1ebe2dad4857eedcbae3a2b6b1c411515139731e2e460f1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:57.44806+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:leadership_role:20","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:samarth-kulkarni-ph-d-crsp","object_label":"Samarth Kulkarni, Ph.D.","object_source_name_forms":[],"value":"Samarth Kulkarni, Ph.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:samarth-kulkarni-ph-d-crsp","name":"Samarth Kulkarni, Ph.D."},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:document:a6f402a1d0006994498d4b437c6a7dbe03aa7dead593633b3e83a95a13a661a2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-03T19:50:46.685108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:committee_record:25","subject_id":"alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair not stated; Members Katherine A. High, M.D.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":null,"members":[{"display_name":"Katherine A. High, M.D.","person_slug":"katherine-a-high-md","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:45.751176+00:00","sources":[{"id":"alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:daad735f770091d40fefe45c7a8218a495b962324bd41308a1292b5147d2fc98","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CRISPR Therapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-03T19:50:01.908+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e9a5c69acc146fbb30c88226413138788ec6364a0fca7d85e4f6197e79f4f3ea","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:57.947188+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b88b7de8b1932f76df41e30ba7cba0c64bd6211bdef2e63f26715c2619a18a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:58.464779+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a8412d5bb50c0528d1ebe2dad4857eedcbae3a2b6b1c411515139731e2e460f1","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-06T18:22:57.44806+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a6f402a1d0006994498d4b437c6a7dbe03aa7dead593633b3e83a95a13a661a2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-03T19:50:46.685108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:a408978f1d28b8720001c2ed21432288beba2d22d1f13ea16ea9b51dd1464e37","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.848,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.875,"cross_source_agreement":0.75,"temporal_completeness":0.833},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":15,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:45.751176+00:00","observed_at":"2026-10-17T04:45:45.751176+00:00","reviewed_at":"2026-10-17T04:45:45.751176+00:00","verified_at":"2026-10-17T04:45:45.751176+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/crispr-therapeutics-ag/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}